Correlation Between Ardelyx and Agios Pharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ardelyx and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ardelyx and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ardelyx and Agios Pharm, you can compare the effects of market volatilities on Ardelyx and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ardelyx with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ardelyx and Agios Pharm.

Diversification Opportunities for Ardelyx and Agios Pharm

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Ardelyx and Agios is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Ardelyx and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Ardelyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ardelyx are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Ardelyx i.e., Ardelyx and Agios Pharm go up and down completely randomly.

Pair Corralation between Ardelyx and Agios Pharm

Given the investment horizon of 90 days Ardelyx is expected to generate 1.1 times more return on investment than Agios Pharm. However, Ardelyx is 1.1 times more volatile than Agios Pharm. It trades about -0.01 of its potential returns per unit of risk. Agios Pharm is currently generating about -0.2 per unit of risk. If you would invest  558.00  in Ardelyx on December 4, 2024 and sell it today you would lose (50.00) from holding Ardelyx or give up 8.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ardelyx  vs.  Agios Pharm

 Performance 
       Timeline  
Ardelyx 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Over the last 90 days Ardelyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Ardelyx is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Agios Pharm 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Agios Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Ardelyx and Agios Pharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ardelyx and Agios Pharm

The main advantage of trading using opposite Ardelyx and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ardelyx position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.
The idea behind Ardelyx and Agios Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine